First single of Mister E album by Breck Stewart, music by 604-ToKaY. The term Mister E is a reference to the drug MDMA commonly known as Ecstasy which is very popular in clubs. It's also a word play on the word mystery. All the songs on Mister E are about the danger of Ecstasy and how it can have a devastating effect on the human brain.
The video was shot and edited with original source 30p HD 1920X1080i then reduced to 1280X720 (hd720) for maximum compatibility with most net settings and web sites. Directed and edited by Breck Stewart with first AD Mario Beauchesne as part of MoonDaze Productions. Featuring Cantelli Canto, St�phanie Tremblay, Jorge Briceno, Francis G, Mario Beauchesne and Jose Luis Mesuro with cameos by Eric, Cindy, Cyb�le, Patricia, Keven, Steve and Pierre. The video was shot at Sky Pub Club in Montreal, Canada.
Premium network EPIX will premiere the new Coldplay tour film Live 2012 as an EPIX Original Concert Event in the U.S. on November 17th, followed by the release of the tour film for purchase on November 20th.
Live 2012 documents Coldplay’s acclaimed Mylo Xyloto world tour, which has been seen by more than three million people since it began in June 2011. It includes footage from Coldplay’s shows at Paris’s Stade de France, Montreal’s Bell Centre and last year’s triumphant Pyramid Stage headline performance at Glastonbury Festival.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56739-epix-to-premiere-coldplay-live-2012-tour-film
The American Society for Aesthetic Plastic Surgery (ASAPS), is hosting a panel discussion about the latest best practices and uses for injectables including the newest FDA-approved options at The Aesthetic Meeting today in Montreal, Quebec Canada.
The panel discussed the latest advances, including the ways various dermal fillers can be utilized to produce optimal results for targeted areas. There are thirteen FDA-approved dermal fillers on the market to-date, providing aesthetic plastic surgeons with the ability to customize anti-aging treatments to patients’ needs. “The filler choices are dictated by a patient’s unique aging pattern, the anatomical area to be treated and physiochemical properties,” explains ASAPS member, Dr. Z. Paul Lorenc.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7310753-asaps-facial-rejuvenation-injectables/
